Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 2-beta-d-ribofuranosylthiazole-4-carboxamide
2. 2-ribofuranosylthiazole-4-carboxamide
3. Nsc 286193
4. Riboxamide
5. Tiazofurin, (alpha-d)-isomer
6. Tiazole
1. Tiazofurine
2. 60084-10-8
3. Riboxamide
4. 2-b-d-ribofuranosyl-4-thiazolecarboxamide
5. Tiazofurinum
6. Tiazofurina
7. Tiazofurin [usan]
8. Tcar
9. Nsc-286193
10. Ci-909
11. Tiazofurine (inn)
12. Tiazofurine [inn]
13. Tiazofurin (usan)
14. 2-beta-d-ribofuranosyl-4-thiazolecarboxamide
15. Ulj82834re
16. Chebi:90239
17. 2-((2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)thiazole-4-carboxamide
18. Tiazofurinum [latin]
19. Tiazofurina [spanish]
20. 2-(beta-d-ribofuranosyl)-4-thiazolecarboxamide
21. (1r)-1,4-anhydro-1-(4-carbamoyl-1,3-thiazol-2-yl)-d-ribitol
22. (1r)-1-[4-(aminocarbonyl)-1,3-thiazol-2-yl]-1,4-anhydro-d-ribitol
23. 2-.beta.-d-ribofuranosyl-4-thiazolecarboxamide
24. Brn 1084555
25. Unii-ulj82834re
26. Cpd-5825
27. 2-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]thiazole-4-carboxamide
28. Tiazofurin [mi]
29. 2-beta-d-ribofuranosylthiazole-4-carboxamide
30. 4-thiazolecarboxamide, 2-beta-d-ribofuranosyl-
31. Schembl4287
32. 2-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3-thiazole-4-carboxamide
33. Tiazofurine [who-dd]
34. Dibutylaminehydrochloride
35. Chembl108358
36. Dtxsid00208827
37. Zinc4217560
38. Bdbm50368057
39. Mfcd00866494
40. Db13243
41. Bs-17271
42. Hy-114570
43. Cs-0063433
44. C22196
45. D06130
46. W18798
47. Q7800305
| Molecular Weight | 260.27 g/mol |
|---|---|
| Molecular Formula | C9H12N2O5S |
| XLogP3 | -1.7 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 3 |
| Exact Mass | 260.04669266 g/mol |
| Monoisotopic Mass | 260.04669266 g/mol |
| Topological Polar Surface Area | 154 Ų |
| Heavy Atom Count | 17 |
| Formal Charge | 0 |
| Complexity | 305 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Antimetabolites, Antineoplastic
Antimetabolites that are useful in cancer chemotherapy. (See all compounds classified as Antimetabolites, Antineoplastic.)
Antineoplastic Agents
Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)
L - Antineoplastic and immunomodulating agents
L01 - Antineoplastic agents
L01X - Other antineoplastic agents
L01XX - Other antineoplastic agents
L01XX18 - Tiazofurine
ABOUT THIS PAGE
78
PharmaCompass offers a list of Tiazofurin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Tiazofurin manufacturer or Tiazofurin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Tiazofurin manufacturer or Tiazofurin supplier.
PharmaCompass also assists you with knowing the Tiazofurin API Price utilized in the formulation of products. Tiazofurin API Price is not always fixed or binding as the Tiazofurin Price is obtained through a variety of data sources. The Tiazofurin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Tiazole manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tiazole, including repackagers and relabelers. The FDA regulates Tiazole manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tiazole API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Tiazole supplier is an individual or a company that provides Tiazole active pharmaceutical ingredient (API) or Tiazole finished formulations upon request. The Tiazole suppliers may include Tiazole API manufacturers, exporters, distributors and traders.
click here to find a list of Tiazole suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Tiazole DMF (Drug Master File) is a document detailing the whole manufacturing process of Tiazole active pharmaceutical ingredient (API) in detail. Different forms of Tiazole DMFs exist exist since differing nations have different regulations, such as Tiazole USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Tiazole DMF submitted to regulatory agencies in the US is known as a USDMF. Tiazole USDMF includes data on Tiazole's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Tiazole USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Tiazole suppliers with USDMF on PharmaCompass.
Tiazole Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tiazole GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tiazole GMP manufacturer or Tiazole GMP API supplier for your needs.
A Tiazole CoA (Certificate of Analysis) is a formal document that attests to Tiazole's compliance with Tiazole specifications and serves as a tool for batch-level quality control.
Tiazole CoA mostly includes findings from lab analyses of a specific batch. For each Tiazole CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tiazole may be tested according to a variety of international standards, such as European Pharmacopoeia (Tiazole EP), Tiazole JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tiazole USP).
